Preferences help
enabled [disable] Abstract
Number of results
2015 | 86 | 11 | 544-551
Article title

Liver Resection for Non-Colorectal, Non-Endocrine Liver Metastasis

Title variants
Languages of publication
Physical description
1 - 9 - 2014
3 - 2 - 2015
  • Department of General, Transplant and Liver Surgery, Warsaw Medical University Kierownik: prof. dr hab.
  • Department of General, Transplant and Liver Surgery, Warsaw Medical University Kierownik: prof. dr hab.
  • Department of General, Transplant and Liver Surgery, Warsaw Medical University Kierownik: prof. dr hab.
  • 1. Dudek K: Czynniki optymalizacji chirurgicznego leczenia chorych z przerzutami raka jelita grubego do wątroby w zależności od stopnia zaawansowania”. Wyd. 1, Oficyna Wydawnicza Warszawskiego Uniwersytetu Medycznego; Warszawa 2013.
  • 2. Adam R, Chiche L, Aloia T et al.: Association Francaise de C. Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann surg 2006; 244: 524-35.
  • 3. de Ridder J, van Walsum m, Verhoef c et al.: Dutch Liver Working G. Hepatic resection for metastatic melanoma in The Netherlands: survival and prognostic factors. Melanoma Res 2013; 23: 27-32.[Crossref]
  • 4. Weitz J, Blumgart LH, Fong Y et al.: Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma. Ann surg 2005; 241: 269-76.
  • 5. Pawlik TM, Zorzi D, Abdalla EK et al.: Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease. Ann Surg Oncology 2006; 13: 712-20.[Crossref]
  • 6. Groeschl RT, Nachmany I, Steel JL et al.: Hepa-tectomy for noncolorectal non-neuroendocrine metastatic cancer: a multi-institutional analysis. J Am Coll Surg 2012; 214: 769-77.
  • 7. Ercolani G, Grazi GL, Ravaioli M et al.: The role of liver resections for noncolorectal, nonneuroen-docrine metastases: experience with 142 observed cases. Ann Surg_ Oncol 2005; 12: 459-66.[Crossref]
  • 8. Elgadi K, Reichman T, Cleary SP: Evaluation and Management of Liver Metastases from Non-gastrointestinal Cancer. In: Brodt P, editor. Liver Metastasis: Biology and Clinical Management: Springer Science + Business Media B.V.; 2011.
  • 9. Er O, Frye DK, Kau SW, Broglio К et al.: Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapy. Cancer J 2008; 14: 62-68.[Crossref][PubMed]
  • 10. Adam R, Aloia T, Krissat J et al.: Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg 2006; 244: 897-907.
  • 11. Belda T, Montalva EM, Lopez-Andujar R et al.: Role of resection surgery in breast cancer liver metastases. Experience over the last 10 years in a reference hospital. Cir Esp 2010; 88: 167-73.[Crossref]
  • 12. Vlastos G, Smith DL, Singletary SE et al.: Longterm survival after an aggressive surgical approach in patients with breast cancer hepatic metastases. Ann Surg Oncol 2004; 11: 869-74.[Crossref]
  • 13. Caralt M, Bilbao I, Cortes J et al.: Hepatic resection for liver metastases as part of the „oncosur-gical” treatment of metastatic breast cancer. Ann Surg Oncol 2008; 15: 2804-10.[Crossref]
  • 14. Thelen A, Benckert C, Jonas S et al.: Liver resection for metastases from breast cancer. J Surg Oncol 2008; 97: 25-9.[Crossref]
  • 15. d'Annibale M, Piovanello P, Cerasoli V et al.: Liver metastases from breast cancer: the role of surgical treatment. Hepatogastroenterology 2005; 52: 1858-62.
  • 16. Chua TC, Liauw W, Koong HN et al.: Surgical therapies in metastatic colorectal cancer with a potential for cure. Am J Clin Oncol 2011; 34: 326-31.[Crossref]
  • 17. Turkyilmaz A, Eroglu A, Aydin Y et al.: Survival in esophageal cancer patients with hematogenous distant organ metastases. Turk J Med Sci 2009; 39: 415-21.
  • 18. Quint Le, Hepburn Lm, Francis IR et al.: Incidence and distribution of distant metastases from newly diagnosed esophageal carcinoma. Cancer 1995; 76: 1120-25.[Crossref]
  • 19. Thelen A, Jonas S, Benckert C et al.: Liver resection for metastatic gastric cancer. Eur J surg oncol 2008; 34: 1328-34.[PubMed][Crossref]
  • 20. Koga R, Yamamoto J, Ohyama S et al.: Liver resection for metastatic gastric cancer: experience with 42 patients including eight longterm survivors. Jpn J clin oncol 2007; 37: 836-42.[Crossref]
  • 21. Dittmar Y, Altendorf-Hofmann A, Rauchfuss F et al.: Resection of liver metastases is beneficial in patients with gastric cancer: report on 15 cases and review of literature. Gastric Cancer 2012; 15: 131-36.[Crossref]
  • 22. Cheon SH, Rha SY, Jeung HC et al.: Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases. Ann Oncol 2008; 19: 1146-53.[Crossref]
  • 23. Elias D, Cavalcanti DE, Albuquerque A, Eggenspieler P et al.: Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients. J Am coll surg 1998; 187: 487-93.
  • 24. Laurent C, Rullier E, Feyler A et al.: Resection of noncolorectal and nonneuroendocrine liver metastases: late metastases are the only chance of cure. World J surg 2001; 25: 1532-36.[PubMed][Crossref]
  • 25. Kerkar SP, Kemp CD, Avital I: Liver resections in metastatic gastric cancer. HPB oxford 2010; 12: 589-96.[Crossref][PubMed]
  • 26. Tsujimoto H, Ichikura T, Ono S et al.: Outcomes for patients following hepatic resection of metastatic tumors from gastric cancer. Hepatol int 2010; 4: 406-13.[Crossref]
  • 27. Takada T, Yasuda H, Amano H et al.: Simultaneous hepatic resection with pancreato-duode-nectomy for metastatic pancreatic head carcinoma: does it improve survival? Hepatogastroenterology 1997; 44: 567-73.
  • 28. Aloia T: Non-colorectal gastrointestinal liver metastases. In: Vauthey JN, editor. Liver Metastases. London: Springer-Verlag; 2009.
  • 29. Bilimoria KY, Bentrem DJ, Wayne JD et al.: Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann surg 2009; 249: 63-71.
  • 30. Dabaja BS, Suki D, Pro B et al.: Adenocarcino-ma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. cancer 2004; 101: 518-26.[Crossref]
  • 31. Gupta K, Miller JD, Li JZ et al.: Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. cancer Treat Rev 2008; 34: 193-205.[PubMed][Crossref]
  • 32. Kim B, Louie AC: Surgical resection following interleukin 2 therapy for metastatic renal cell carcinoma prolongs remission. Arch surg 1992; 127: 1343-49.
  • 33. Aloia TA, Adam R, Azoulay D et al.: Outcome following hepatic resection of metastatic renal tumors: the Paul Brousse Hospital experience. HPB oxford 2006; 8: 100-05.[Crossref]
  • 34. Staehler MD, Kruse J, Haseke N et al.: Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis. World J Urol 2010; 28: 543-47.
  • 35. Thelen A, Jonas S, Benckert C et al.: Liver resection for metastases from renal cell carcinoma. World J surg 2007; 31: 802-07.[PubMed][Crossref]
  • 36. Hatzaras I, Gleisner AL, Pulitano C et al.: A multi-institution analysis of outcomes of liver-directed surgery for metastatic renal cell cancer. HPB oxford 2012; 14: 532-38.[PubMed][Crossref]
  • 37. Bosl GJ, Motzer RJ: Testicular germ-cell cancer. N Engl J Med 1997; 337: 242-53.
  • 38. Hartmann JT, Rick O, Oechsle Ket al.: Role of postchemotherapy surgery in the management of patients with liver metastases from germ cell tumors. Ann surg 2005; 242: 260-66.[Crossref][PubMed]
  • 39. Yoon SS, Jarnagin WR, Fong Y et al.: Resection of recurrent ovarian or fallopian tube carcinoma involving the liver. Gynecol oncol 2003; 91: 383-88.[Crossref]
  • 40. Kawagishi N, shirahata Y, Ishida K et al.: Hepatic resection of giant metastatic tumor from clear cell carcinoma of the ovary. J Hepatobiliary Pancreat surg 2005; 12: 155-58.[PubMed]
  • 41. Abood G, Bowen M, Potkul R et al.: Hepatic resection for recurrent metastatic ovarian cancer. Am J surg 2008; 195: 370-73.
  • 42. Chalkiadakis GE, Lasithiotakis KG, Petrakis I et al.: Major hepatectomy and right hemicolectomy at the time of primary cytoreductive surgery for advanced ovarian cancer: report of a case. Int J Gynecol cancer 2005; 15: 1115-19.[Crossref][PubMed]
  • 43. Tangjitgamol S, Levenback CF, Beller U et al.: Role of surgical resection for lung, liver, and central nervous system metastases in patients with gynecological cancer: a literature review. Int J Gynecol cancer 2004; 14: 399-422.[PubMed][Crossref]
  • 44. Ileana E, Greillier L, Moutardier Vet al.: Surgical resection of liver non-small cell lung cancer metastasis: a dual weapon? Lung cancer 2010; 70: 221-22.[Crossref]
  • 45. Song HJ, Xue YL, Xu YH et al.: Rare metastases of differentiated thyroid carcinoma: pictorial review. Endocr Relat cancer 2011; 18: 165-74.[Crossref]
  • 46. Bradley PJ: Distant metastases from salivary glands cancer. oRL J otorhinolaryngol Relat spec 2001; 63: 233-42.[PubMed]
  • 47. Deshpande AH, Kelkar AA: Hepatic metastasis as an initial manifestation of salivary adenoid cystic carcinoma: Cytologic diagnosis. Diagn cytopathol 2009; 37: 45-47.[Crossref][PubMed]
  • 48. Kebebew E, Reiff E, Duh QY et al.: Extent of disease at presentation and outcome for adrenocor-tical carcinoma: have we made progress? World J Surg 2006; 30: 872-78.[Crossref]
  • 49. Ripley RT, Kemp CD, Davis JL et al.: Liver resection and ablation for metastatic adrenocortical carcinoma. Ann surg oncol 2011; 18: 1972-79.[Crossref][PubMed]
  • 50. Berruti A, Terzolo M, Sperone P et al.: Etoposi-de, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial. Endocr relat cancer 2005; 12: 657-66.[Crossref]
  • 51. Lendoire J, Mow M, Andriani O et al.: Liver resection for non-colorectal, non-neuroendocrine metastases: analysis of a multicenter study from Argentina. HPB (oxford) 2007; 9: 435-39.[PubMed]
  • 52. Orourke TR, Tekkis P, Yeung S et al.: Longterm results of liver resection for non-colorectal, non-neuroendocrine metastases. Ann surg oncol 2008; 15: 207-18.[Crossref]
  • 53. Ercolani G, Vetrone G, Grazi Gl et al.: The role of liver surgery in the treatment of non-colorectal non-neuroendocrine metastases (NCRNNE). Analysis of 134 resected patients. Minerva chir 2009; 64: 551-58.
  • 54. Lehner F, ramackers W, Bektas H et al.: (Liver resection for non-colorectal, non-neuroendocrine liver metastases–is hepatic resection justified as part of the oncosurgical treatment?). zentralbl chir 2009; 134: 430-36.
  • 55. Lubrano J, roman H, Tarrab S et al.: Liver resection for breast cancer metastasis: does it improve survival? surg today 2008; 38: 293-99.[Crossref]
  • 56. Meloni MF, Andreano A, Laeseke PF et al.: Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation - intermediate and long-term survival rates. radiology 2009; 253: 861-69.
  • 57. Garancini M, Uggeri F, Degrate L et al.: Surgical treatment of liver metastases of gastric cancer: is local treatment in a systemic disease worthwhile? HPB (oxford) 2012; 14: 209-15.
  • 58. Yang XW, Li Z, Liu K et al.: Correlation between the survival rate of the patients with synchronous hepatic metastases from gastric carcinoma after surgical resection and patient's index. chin Med J (Engl) 2012; 125: 747-51.
  • 59. Berney T, Mentha G, Roth AD et al.: Results of surgical resection of liver metastases from non-colorectal primaries. Br J surg 1998; 85: 1423-27.
  • 60. Yamada H, Hirano S, Tanaka E et al.: Surgical treatment of liver metastases from pancreatic cancer. HPB (Oxford) 2006; 8: 85-88.[PubMed]
  • 61. Gleisner AL, Assumpcao L, Cameron JL et al.: Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified? cancer 2007; 110: 2484-92.[PubMed][Crossref]
  • 62. Hartwig W, Denneberg M, Bergmann F et al.: Acinar cell carcinoma of the pancreas: is resection justified even in limited metastatic disease? Am J surg 2011; 202: 23-27.
  • 63. Klein F, Puhl G, Guckelberger O et al.: The impact of simultaneous liver resection for occult liver metastases of pancreatic adenocarcinoma. Gastroenterol res Pract 2012; 939350.[PubMed]
  • 64. Benevento A, Boni L, Frediani L et al.: Result of liver resection as treatment for metastases from noncolorectal cancer. J surg oncol 2000; 74: 24-29.[Crossref]
  • 65. Kornasiewcz O: Wartość leczenia chirurgicznego chorych z przerzutami do wątroby innymi niż przerzuty z raka jelita grubego i nowotworów neu-roendokrynnych. Wyd. 1. Oficyna Wydawnicza Warszawskiego Uniwersytetu Medycznego; Warszawa 2013.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.